stephen silberstein, md, director, jefferson university headache center..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
.
no wonder he needs such a large army of trained helpers in and around the press..
the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted..